■2021年

1. Surgical treatment of hemophilic pseudotumor with severe bone destruction: a case report
＊Kumiko Ono, Akihiko Matsumine, Megumi Noguchi, Kayoko Asano, Masaaki Yasuda, Hideyuki Takedani
Mod Rheumatol Case Rep. 2021 Feb 18:1-7

■2020年

1. Long-term impact of haemarthrosis on arthropathy and activities of daily living in Japanese persons with haemophilia.
Fujii T, Fujii T, Takedani H.
Haemophilia. 2020 May;26(3):e124-e127

2. Risk of deep venous thrombosis after total knee arthroplasty in patients with haemophilia A
＊Kumiko Ono, Hideyuki Takedani
Haemophilia. 2020 Sep;26(5):867-872

3. 「NDBオープンデータからみた骨関連折手術と骨粗鬆症治療薬における性年齢別の動向」
大野久美子、山田浩司、齋藤琢、田中栄
日本骨粗鬆症学会誌　2020, vol.6, No.3, p.319-325

■2019年

1. Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII.
Kearney S, Raffini LJ, Pham TP, Lee XY, von Mackensen S, Landorph A, Takedani H, Oldenburg J.
Patient Prefer Adherence. 2019 Apr 9;13:497-513

2. Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.
Nagao A, Suzuki N, Takedani H, Yamasaki N, Chikasawa Y, Sawada A, Kanematsu T, Nojima M, Higasa S, Amano K, Fukutake K, Fujii T, Matsushita T, Suzuki T.
Haemophilia. 2019 Jul;25(4):e223-e230

3. Physical activity and its related factors in Japanese people with haemophilia.
Goto M, Haga N, Takedani H.
Haemophilia. 2019 Jul;25(4):e267-e273

4. Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitors.
Shirayama R, Takedani H, Chikasawa Y, Ishiguro A, Ishimura M, Isobe K, Uchiba M, Ogata Y, Kakuda H, Kusuhara K, Shirahata A.
Blood Coagul Fibrinolysis. 2019 Dec;30(8):385-392


■2018年

1. Orthotropic live transplantation for cirrhosis from hepatitis C virus leads to correction of factor IX deficiency allowing for ankle arthroplasty without factor replacement in a patient with moderate haemophilia B.

Ono K, Hirose J, Chang SH, Kubota M, Kinkawa J, Noguchi M, Takedani H.

Blood Coagul Fibrinolysis. 2018 Jan;29(1):131-134.

2. Perioperative safety and hemostatic efficacy of AdvateR in patients with hemophilia A in a postmarketing surveillance in Japan.

Nogami K, Takedani H, Shima M, Yoshioka A, Matsushita T, Takamatsu J, Taki M, Fukutake K, Uchikawa H, Takagi H, Arai M, Engl W, Shirahata A.

Int J Hematol. 2018 Mar 28.

3. A case report on a multicentre cooperative rehabilitation programme for inhibitor-positive patients with haemophilia A.

Kubota M, Takedani H, Ono K, Noguchi M, Nakata A, Oka T.

Haemophilia. 2018 May 23.

■2017年

1. A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.

Shinkoda Y, Shirahata A, Fukutake K, Takamatsu J, Shima M, Hanabusa H, Mugishima H, Takedani H, Kawasugi K, Taki M, Matsushita T, Tawa A, Nogami K, Higasa S, Kosaka Y, Fujii T, Sakai M, Migita M, Uchiba M, Kawakami K, Sameshima K, Ohashi Y, Saito H.

Haemophilia. 2017 Jan;23(1):59-66.

2. Usefulness of a simple self-administered joint condition assessment sheet to predict the need for orthopaedic intervention in the management of haemophilic arthropathy.

Masaoka T, Amano K, Takedani H, Suzuki T, Otaki M, Seita I, Tateiwa T, Shishido T, Yamamoto K, Fukutake K.

Haemophilia. 2017 Mar;23(2):e116-e123.

 
3. The Haemophilia Joint Visualizer: development of a personalized, interactive, web-based tool to help improve adherence to prophylaxis.

Takedani H, Solimeno L, Saxena K, Kalweit L, Mathew P.

Haemophilia. 2017 Mar;23(2):e155-e158.

4. First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A.

Hampton K, Chowdary P, Dunkley S, Ehrenforth S, Jacobsen L, Neff A, Santagostino E, Sathar J, Takedani H, Takemoto CM, Negrier C.

Haemophilia. 2017 Sep;23(5):689-696.

5. Arthroscopic debridement for advanced haemophilic ankle arthropathy.

Yasui T, Hirose J, Ono K, Takedani H.

Haemophilia. 2017 Sep;23(5):e479-e481.

■2016年

1. Strategies to encourage physical activity in patients with hemophilia to improve quality of life.

Goto M, Takedani H, Yokota K, Haga N.

J Blood Med. 2016 May 17;7:85-98.

2. A successful physiotherapy management case of a patient with acquired haemophilia A prior to factor VIII inhibitor eradication.

Goto M, Haga N, Yokota K, Takamizawa K, Takedani H.

Haemophilia. 2016 May;22(3):e228-31.

3. Total hip arthroplasty and total knee arthroplasty in a patient with congenital deficiency of plasminogen activator inhibitor-1.

Hirose J, Takedani H, Kubota M, Kinkawa J, Noguchi M.

Haemophilia. 2016 May;22(3):e237-9.

4. Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent.

Takedani H, Hirose J, Minamoto F, Kubota M, Kinkawa J, Noguchi M.

Haemophilia. 2016 Sep;22(5):e459-61.

■2015年

1. Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A.

Takedani H, Hirose J.

Drug Des Devel Ther. 2015 Mar 24;9:1767-72.

2. Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan.

Takedani H, Shima M, Horikoshi Y, Koyama T, Fukutake K, Kuwahara M, Ishiguro N.

Haemophilia. 2015 May;21(3):374-9.

3. Deep venous thrombosis was not detected after total knee arthroplasty in Japanese patients with haemophilia.

Takedani H, Ohnuma K, Hirose J.

Haemophilia. 2015 Sep;21(5):585-8.

4. The features of clearance in recombinant factor IX (BeneFIX(R) ).

Suzuki N, Takedani H, Hirakawa A, Ushijima Y, Matsushita T.

Haemophilia. 2015 Sep;21(5):702-7.

 
5. Joint Function and Arthropathy Severity in Patients with Hemophilia.

Goto M, Takedani H, Nitta O, Kawama K.

J Jpn Phys Ther Assoc. 2015;18(1):15-22.

■2014年

1. Continuous infusion of rFVIIa during surgery in a FVII-deficient patient: a case report from Japan.

Nagao A, Hanabusa H, Takedani H.

Haemophilia. 2014 Jan;20(1):e110-2.

2. Self-monitoring has potential for home exercise programmes in patients with haemophilia.

Goto M, Takedani H, Haga N, Kubota M, Ishiyama M, Ito S, Nitta O.

Haemophilia. 2014 Mar;20(2):e121-7.

3. Rehabilitation improved walking ability for three haemophilia patients with inhibitors.

Shimokawa A, Takedani H.

Haemophilia. 2014 May;20(3):e222-4.

■2013年

1. Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd report.

Shirahata A, Fukutake K, Mimaya J, Takamatsu J, Shima M, Hanabusa H, Takedani H, Takashima Y, Matsushita T, Tawa A, Higasa S, Takata N, Sakai M, Kawakami K, Ohashi Y, Saito H.

Haemophilia. 2013 Mar;19(2):330-7.

2. Feasibility of autologous bone marrow mesenchymal stem cells cultured with autologous serum for treatment of haemophilic arthropathy.

Ebihara Y, Takedani H, Ishige I, Nagamura-Inoue T, Wakitani S, Tojo A, Tsuji K.

Haemophilia. 2013 Mar;19(2):e87-9.

3. A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.

Shirahata A, Fukutake K, Takamatsu J, Shima M, Hanabusa H, Mugishima H, Amano K, Takedani H, Tamashima S, Matsushita T, Tawa A, Tanaka I, Higasa S, Kosaka Y, Fujii T, Sakai M, Migita M, Kawakami K, Ohashi Y, Saito H.

Haemophilia. 2013 Nov;19(6):853-60.

4. The risk of elective orthopaedic surgery for haemophilia patients: Japanese single-centre experience.

Hirose J, Takedani H, Koibuchi T.

Haemophilia. 2013 Nov;19(6):951-5.

■2012年

1. Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trial.

Shirahata A, Fukutake K, Mimaya J, Takamatsu J, Shima M, Hanabusa H, Takedani H, Takashima Y, Matsushita T, Tawa A, Higasa S, Takata N, Sakai M, Kawakami K, Ohashi Y, Saito H.

Haemophilia. 2012 Jan;18(1):94-101.

2. Arthroscopic synovectomy of the elbow covered with rFVIIa in a haemophilia B juvenile with inhibitor.

Shimada K, Takedani H, Inoue K, Yamasaki K.

Haemophilia. 2012 Nov;18(6):e414-6.

■2011年

1. Inter-observer reliability of three different radiographic scores for adult haemophilia.

Takedani H, Fujii T, Kobayashi Y, Haga N, Tatsunami S, Fujii T.

Haemophilia. 2011 Jan;17(1):134-8.

■2010年

1. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa.

Takedani H, Kawahara H, Kajiwara M.

Haemophilia. 2010 Mar;16(2):290-5